In an interview with Pharm Exec Associate Editor Don Tracy, Melissa Lattanzi, Vice President of Emerging Therapies at Cencora, discusses what questions cell and gene therapy developers need to answer to inform their sales strategy. It provides an overview of what is there.
Cencora’s VP of Emerging Therapies talks about cell and gene therapy distribution strategy
Leave a comment
